Jasmin A. Tiro named associate director of Cancer Prevention and Population Sciences at UChicago

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

UChicago Medicine received a $75 million donation from the AbbVie Foundation, a nonprofit focused on advancing health equity, to help fund the construction of the new cancer care and research pavilion.

November 01, 2024

Vol.50 No.41

In the Archives

UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC

Two former directors and the current director of the UChicago Medicine Comprehensive Cancer Center appeared in a special episode of the Cancer Luminaries podcast. This series was launched by UCCCC to mark its 50th year as an NCI-designated cancer center.

October 18, 2024

Vol.50 No.39

In Brief

Jane Figueiredo appointed co-leader of Cancer Prevention and Control Program at Cedars-Sinai

Jane Figueiredo was appointed co-leader of the Cancer Prevention and Control Program at Cedars-Sinai Cancer Center.

October 11, 2024

Vol.50 No.38

In the Archives

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Jose and Irma Russo dedicated their careers to investigating breast cancer, its causes, and potential prevention measures.

September 27, 2024

Vol.50 No.36

Clinical Trials & Tribulations

Is gastrectomy indicated?
A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?

A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates.

September 06, 2024

Vol.50 No.33

By Rebecca Sutphen, Sue Friedman and Jon Florin

In the Archives

Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast

Huiping Liu, associate professor of pharmacology and medicine at Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, appeared on the Cancer Luminaries podcast. This series was launched by the UChicago Medicine Comprehensive Cancer Center to mark its 50th year as an NCI-designated center.

September 06, 2024

Vol.50 No.33

Jasmin A. Tiro named associate director of Cancer Prevention and Population Sciences at UChicago

YOU MAY BE INTERESTED IN

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC

Jane Figueiredo appointed co-leader of Cancer Prevention and Control Program at Cedars-Sinai

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Is gastrectomy indicated?
A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?

Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast

Renew today!

Subscriber content

Never miss an issue!

Login

Jasmin A. Tiro named associate director of Cancer Prevention and Population Sciences at UChicago

YOU MAY BE INTERESTED IN

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

UChicago Cancer Luminaries podcast interviews Odunsi, Le Beau, and Schilsky about running UCCCC

Jane Figueiredo appointed co-leader of Cancer Prevention and Control Program at Cedars-Sinai

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Is gastrectomy indicated?A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?

Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast

Never miss an issue!

Login

Is gastrectomy indicated?
A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?